Susquehanna International Group
PBE icon

Susquehanna International Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Susquehanna International Group’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$586K Buy
7,403
+2,799
+61% +$226K ﹤0.01% 9248
2025
Q4 		$378K Buy
+4,604
New +$356K ﹤0.01% 9423
2025
Q3 		– Sell
-6,498
Closed -$417K – 13512
2025
Q2 		$417K Buy
6,498
+1,340
+26% +$83K ﹤0.01% 9592
2025
Q1 		$327K Sell
5,158
-10,981
-68% -$739K ﹤0.01% 9886
2024
Q4 		$1.07M Sell
16,139
-1,239
-7% -$85.4K ﹤0.01% 6777
2024
Q3 		$1.21M Buy
+17,378
New +$1.2M ﹤0.01% 6355
2024
Q2 		– Sell
-3,348
Closed -$217K – 12925
2024
Q1 		$217K Sell
3,348
-5,443
-62% -$354K ﹤0.01% 10442
2023
Q4 		$579K Sell
8,791
-2,592
-23% -$151K ﹤0.01% 8299
2023
Q3 		$649K Sell
11,383
-1,050
-8% -$64K ﹤0.01% 7618
2023
Q2 		$762K Sell
12,433
-3,914
-24% -$244K ﹤0.01% 7321
2023
Q1 		$1.03M Sell
16,347
-643
-4% -$41.4K ﹤0.01% 6744
2022
Q4 		$1.08M Buy
+16,990
New +$1.08M ﹤0.01% 6022
2022
Q2 		– Sell
-11,405
Closed -$707K – 13665
2022
Q1 		$707K Buy
11,405
+1,644
+17% +$100K ﹤0.01% 8055
2021
Q4 		$695K Buy
+9,761
New +$707K ﹤0.01% 8284
2021
Q3 		– Sell
-15,331
Closed -$1.19M – 13335
2021
Q2 		$1.19M Buy
+15,331
New +$1.14M ﹤0.01% 7285
2020
Q4 		– Sell
-12,900
Closed -$730K – 11542
2020
Q3 		$730K Sell
12,900
-19,771
-61% -$1.16M ﹤0.01% 6869
2020
Q2 		$1.9M Buy
32,671
+11,003
+51% +$599K ﹤0.01% 4586
2020
Q1 		$1.01M Sell
21,668
-16,036
-43% -$836K ﹤0.01% 5383
2019
Q4 		$2.11M Sell
37,704
-2,306
-6% -$120K ﹤0.01% 4241
2019
Q3 		$1.9M Buy
40,010
+30,713
+330% +$1.57M ﹤0.01% 4302
2019
Q2 		$498K Sell
9,297
-23,278
-71% -$1.21M ﹤0.01% 7267
2019
Q1 		$1.8M Buy
32,575
+10,768
+49% +$569K ﹤0.01% 3925
2018
Q4 		$1.03M Buy
21,807
+18,276
+518% +$939K ﹤0.01% 4615
2018
Q3 		$210K Buy
+3,531
New +$206K ﹤0.01% 8128
2018
Q2 		– Sell
-31,636
Closed -$1.56M – 10166
2018
Q1 		$1.56M Sell
31,636
-4,637
-13% -$237K ﹤0.01% 4384
2017
Q4 		$1.71M Sell
36,273
-11,137
-23% -$522K ﹤0.01% 4189
2017
Q3 		$2.37M Buy
47,410
+183
+0.4% +$8.68K ﹤0.01% 3604
2017
Q2 		$2.16M Buy
47,227
+5,071
+12% +$219K ﹤0.01% 3784
2017
Q1 		$1.78M Buy
+42,156
New +$1.77M ﹤0.01% 3946
2016
Q4 		– Sell
-17,873
Closed -$750K – 9981
2016
Q3 		$750K Buy
17,873
+526
+3% +$21.6K ﹤0.01% 5335
2016
Q2 		$642K Sell
17,347
-5,326
-23% -$209K ﹤0.01% 5689
2016
Q1 		$868K Buy
+22,673
New +$881K ﹤0.01% 5374
2015
Q4 		– Sell
-68,328
Closed -$3.12M – 9806
2015
Q3 		$3.12M Buy
68,328
+47,136
+222% +$2.63M ﹤0.01% 3429
2015
Q2 		$1.24M Buy
21,192
+447
+2% +$25.6K ﹤0.01% 5743
2015
Q1 		$1.14M Buy
+20,745
New +$1.12M ﹤0.01% 5471
2014
Q4 		– Sell
-10,261
Closed -$474K – 9962
2014
Q3 		$474K Sell
10,261
-18,272
-64% -$823K ﹤0.01% 7312
2014
Q2 		$1.25M Sell
28,533
-78,246
-73% -$3.17M ﹤0.01% 5585
2014
Q1 		$4.45M Buy
106,779
+98,862
+1,249% +$4.23M ﹤0.01% 3059
2013
Q4 		$293K Buy
+7,917
New +$284K ﹤0.01% 7614

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Susquehanna International Group's PBE Position: Q1 2026 in Review

Susquehanna International Group increased its Invesco Biotechnology & Genome ETF (PBE) stake by 61% in Q1 2026, buying an estimated $226K and bringing the position to 7,403 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #9248.

Susquehanna International Group first reported a position in PBE in Q4 2013 and has held it in 39 quarters since. The position peaked at $4.45M in Q1 2014. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Susquehanna International Group held 7,403 shares of Invesco Biotechnology & Genome ETF worth $586K as of Q1 2026.
  • Susquehanna International Group bought 2,799 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $226K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9248 holding.
  • Susquehanna International Group first reported a position in Invesco Biotechnology & Genome ETF in Q4 2013 and has held it in 39 quarters since.
  • Susquehanna International Group's Invesco Biotechnology & Genome ETF position peaked at $4.45M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.